SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: EX-1.2
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea026681201ex1-2_synergy.htm

Chunk 17 of 18
Word Count: 1237
Character Count: 7671

Document Content:

the Agents shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company, other than in respect of the Agents’ obligations under this Agreement and to keep information provided by the Company to the Agents and the Agents’ counsel confidential to the extent not otherwise publicly-available. 24. Definitions. As used in this Agreement, the following terms have the respective meanings set forth below: “Applicable Time” means (i) each Representation Date, (ii) the time of each sale of any Placement Shares pursuant to this Agreement, and (iii) each Settlement Date. “Business Day” shall mean any day on which the Exchange and commercial banks in the City of New York are open for business.

“Issuer Free Writing
Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433, relating to the Placement Shares
that (1) is required to be filed with the Commission by the Company, (2) is a “road show” that is a “written communication”
within the meaning of Rule 433(d)(8)(i) whether or not required to be filed with the Commission, or (3) is exempt from filing pursuant
to Rule 433(d)(5)(i) because it contains a description of the Placement Shares or of the offering that does not reflect the final terms,
in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the
Company’s records pursuant to Rule 433(g) under the Securities Act.

“Rule 172,”
“Rule 405,” “Rule 415,” “Rule 424,” “Rule 424(b),” “Rule
430B,” and “Rule 433” refer to such rules under the Securities Act.

“Trading Day” means any day on which shares of Common Stock are purchased and sold on the
Exchange.

All references in this Agreement
to financial statements and schedules and other information that is “contained,” “included” or “stated”
in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such
financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus,
as the case may be.

All references in this Agreement
to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy
filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing Prospectus (other than any Issuer
Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission) shall be deemed to include the
copy thereof filed with the Commission pursuant to EDGAR; and all references in this Agreement to “supplements” to the Prospectus
shall include, without limitation, any supplements, “wrappers” or similar materials prepared in connection with any offering,
sale or private placement of any Placement Shares by the Agents outside of the United States.

If the foregoing correctly
sets forth the understanding between the Company and the Agents, please so indicate in the space provided below for that purpose, whereupon
this Agreement shall become binding between the Company and the Agents.

SYNERGY CHC CORP.

By:	/s/ Jack Ross

Name:	Jack Ross

Title:	Chief Executive Officer

ACCEPTED as of the date first-above written:

ROTH CAPITAL PARTNERS, LLC

By:	/s/ Joe Tonnos

Name:	Joe Tonnos

Title:	Managing Director, Investment Banking

BANCROFT CAPITAL, LLC

By:	/s/ Jason Diamond

Name:	Jason Diamond

Title:	Head of Investment Banking

[Signature Page to Sales
Agreement]

SCHEDULE 1

FORM OF PLACEMENT NOTICE

From:	SYNERGY CHC CORP.

To:	ROTH CAPITAL PARTNERS, LLC

Attention:

Subject:	Placement Notice Date:

Gentlemen:

Pursuant to the terms and
subject to the conditions contained in the Sales Agreement between Synergy CHC Corp. (the “Company”) and Roth Capital Partners,
LLC (the “Lead Agent”) and Bancroft Capital, LLC (an “Agent” and together with the Lead Agent, the “Agents”),
dated November 26, 2025, the Company hereby requests that the Lead Agent sell up to
of the Company’s common stock, $0.00001 par value per share, at a minimum market price of $
per share, during the time period beginning [month, day, time] and ending [month, day, time].

SCHEDULE 2

Compensation

The Company shall pay to the Lead Agent in cash,
upon each sale of Placement Shares pursuant to this Agreement, an amount equal to 3% of the gross proceeds from such sale of Placement
Shares.

SCHEDULE 3

Notice Parties

The
Company

Jack Ross

The Lead Agent

rothecm@roth.com

The Agent

InvestmentBanking@bancroft4vets.com

By Mail:

Bancroft Capital LLC

Attn: Jason Diamond

501 Office Center Drive, Ste 130

Fort Washington, PA 19034

EXHIBIT 7(m)

Form of Representation Date Certificate

This Representation Date Certificate
(this “Certificate”) is executed and delivered in connection with Section 7(m) of the Sales Agreement (the “Agreement”),
dated November 26, 2025, and entered into between Synergy CHC Corp. (the “Company”) and Roth Capital Partners, LLC and Bancroft
Capital, LLC. All capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement.

The undersigned, a duly appointed
and authorized officer of the Company, having made all necessary inquiries to establish the accuracy of the statements below and having
been authorized by the Company to execute this Certificate, hereby certifies as follows:

1.	As of the date of this Certificate, (i) the Registration Statement does not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein
not misleading and (ii) neither the Registration Statement nor the Prospectus contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading and (iii) no event has occurred as a result of which it is necessary to amend or supplement
the Prospectus in order to make the statements therein not untrue or misleading.

2.	Each of the representations and warranties of the Company contained in the Agreement were, when originally
made, and are, as of the date of this Certificate, true and correct in all material respects.

3.	Each of the covenants required to be performed by the Company in the Agreement on or prior to the date
of the Agreement, this Representation Date, and each such other date as set forth in the Agreement, has been duly, timely and fully performed
in all material respects and each condition required to be complied with by the Company on or prior to the date of the Agreement, this
Representation Date, and each such other date as set forth in the Agreement has been duly, timely and fully complied with in all material
respects.

4.	Subsequent to the date of the most recent financial statements in the Prospectus, there has been no Material
Adverse Effect.

5.	No stop order suspending the effectiveness of the Registration Statement or of any part thereof has been
issued, and no proceedings for that purpose have been instituted or are pending or, to the Company’s knowledge threatened by any
securities or other governmental authority (including, without limitation, the Commission).

The undersigned has executed
this Representation Date Certificate as of the date first written above.

SYNERGY CHC CORP.

Name:

Title: